Company News

MRI Interventions to Exhibit Its ClearPoint(R) Neuro Navigation System for Neurosurgery at CNS 2015 Annual Meeting

Download PDF

IRVINE, Calif., Sept. 15, 2015 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be on exhibit at the Congress of Neurological Surgeons (CNS) 2015 Annual Meeting September 26 - 30, 2015, in New Orleans, LA and will also be featured in the Innovations Showcase. CNS attendees are invited to visit the MRI Interventions booth (#426) to learn about the ClearPoint system's unique real-time MRI guidance capability that enables surgeons to perform a wide range of minimally-invasive neurosurgical procedures.

"We are looking forward to this opportunity to showcase our ClearPoint System for MRI-guided neuro navigation. In particular, we are pleased to be co-sponsoring with Medtronic a ninety minute educational Lunch and Learn Symposium entitled, 'The Emergence of Real-Time Imaging in Neurosurgery,'" stated Wendelin Maners, Vice President, Marketing for MRI Interventions.  "Adoption of our technology is growing, and surgeons on the forefront of this advanced approach to neurosurgery, including Drs. Paul Larson, Robert Gross and Jon T. Willie, will be presenting their perspective on the technology."

The ClearPoint system is the only neuro navigation system which allows surgeons to plan, target, and adjust trajectories under real time MRI-guided visualization for placement of electrodes, catheters and biopsy needles.

About MRI Interventions, Inc.

Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The Company's ClearPoint system utilizes a hospital's existing diagnostic or intraoperative MRI scanner to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias. For more information, please visit

Forward-Looking Statements

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Particular uncertainties and risks include those relating to: future revenues from sales of the Company's ClearPoint system products; the Company's ability to market, commercialize and achieve broader market acceptance for the Company's ClearPoint system products; estimates regarding the sufficiency of the Company's cash resources; and the Company's ability to obtain additional financing. More detailed information on these and additional factors that could affect the Company's actual results are described in the "Risk Factors" sections of the Company's Form 10-K for the year ended December 31, 2014 and Form 10-Q for the quarter ended June 30, 2015, both of which have been filed with the Securities and Exchange Commission.

CONTACT: Wendelin Maners, VP, Marketing
         MRI Interventions, Inc.

MRI Interventions, Inc. logo

Source: MRI Interventions, Inc.